Clinical Trials Browser

Phase 3 × belzutifan × 90 days × Clear all

NCT07227402 2026-03-16

LITESPARK-033

Phase 3 Recruiting

Carcinoma, Carcinoma, Renal Cell

NCT07405164 2026-02-12

MK-6482-043

Phase 3 Not yet recruiting

Carcinoma, Renal Cell, von Hippel-Lindau Disease